Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRDL
CRDL logo

CRDL Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cardiol Therapeutics Inc (CRDL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.010
1 Day change
-5.61%
52 Week Range
1.710
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CRDL is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is hovering around key support with mixed momentum, but the broader trend is still bearish and there is no strong catalyst or proprietary buy signal to justify an immediate purchase. For an impatient buyer who does not want to wait for a better entry, I would still not buy here; holding off is the better choice.

Technical Analysis

Price closed at 1.0232, below the 1.049 pivot and near S1 at 1.011, showing weak short-term positioning. MACD histogram is positive and expanding, which suggests a small improving momentum shift, but RSI_6 at 46.47 is neutral and not confirming strength. The moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, which indicates the primary trend is still down. Immediate resistance is 1.087 (R1), then 1.111 (R2), while support sits at 1.011 and 0.987. Overall, the technical picture is weak to neutral rather than bullish.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is extremely call-heavy based on open interest, with a put-call ratio of 0.01. That usually implies bullish positioning, but the lack of actual option volume today means there is no strong confirmation from fresh trading activity. IV percentile at 100 and IV rank at 102.94 indicate elevated implied volatility relative to history, which often reflects event risk or speculative positioning rather than clean long-term conviction. Net options data leans bullish on positioning, but the low volume makes it less actionable.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
12
Buy
2

Positive Catalysts

  • ["MACD histogram is above zero and expanding, suggesting momentum is improving from a weak base.", "Options open interest is heavily call-skewed, which shows bullish sentiment in positioning.", "The stock is trading close to support, which could attract dip buyers if a rebound starts.", "Similar candlestick pattern analysis suggests modest near-term upside probability."]

Neutral/Negative Catalysts

  • ["No news in the past week, so there is no fresh catalyst to drive a sustained move.", "Moving averages are bearish, showing the longer-term trend remains weak.", "RSI is neutral, so there is no strong momentum confirmation.", "No recent AI Stock Picker or SwingMax signal is present.", "Hedge funds and insiders are both neutral, with no meaningful accumulation signal.", "No recent congress trading activity was reported.", "Post-market change was negative, which does not support immediate strength."]

Financial Performance

No usable latest-quarter financial snapshot was provided due to an error, so there is no reliable financial growth readout to assess. The latest quarter season cannot be confirmed from the supplied data. Based on the available dataset, there is no evidence here of accelerating revenue, earnings, or margin improvement that would support a long-term beginner-friendly buy.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible Wall Street upgrades/downgrades trend to summarize. In the absence of analyst support, the Wall Street pros and cons view leans cautious: pros are speculative upside from low-price positioning and call-heavy options, while cons are weak trend structure, no catalyst, and no clear fundamental confirmation. Overall analyst sentiment cannot be confirmed, but the available evidence does not point to strong buy-side conviction.

Wall Street analysts forecast CRDL stock price to rise
2 Analyst Rating
Wall Street analysts forecast CRDL stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.070
sliders
Low
8
Averages
8.5
High
9
Current: 1.070
sliders
Low
8
Averages
8.5
High
9
No data

No data

People Also Watch